Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/blueprint-medicines-to-report-first-quarter-2024-financial-results-on-thursday-may-2-2024-302119817.html
https://www.prnewswire.com/news-releases/blueprint-medicines-to-host-webcast-and-conference-call-highlighting-emerging-opportunities-for-mast-cell-targeted-therapeutics-302113503.html
https://www.prnewswire.com/news-releases/blueprint-medicines-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302107803.html
https://www.prnewswire.com/news-releases/blueprint-medicines-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-302081437.html
https://www.prnewswire.com/news-releases/blueprint-medicines-highlights-ayvakit-avapritinib-long-term-efficacy-and-safety-data-and-advances-in-mast-cell-disease-research-at-2024-aaaai-annual-meeting-302069445.html
https://www.prnewswire.com/news-releases/blueprint-medicines-reports-fourth-quarter-and-full-year-2023-results-302062427.html
https://www.fiercepharma.com/pharma/blueprint-boosts-ayvakit-peak-sales-estimate-2b-key-rare-disease-expansion-accelerates
https://ir.blueprintmedicines.com/news-releases/news-release-details/blueprint-medicines-announces-inducement-grants-under-nasdaq-43
https://ir.blueprintmedicines.com/news-releases/news-release-details/blueprint-medicines-report-fourth-quarter-and-full-year-2023
https://www.fiercebiotech.com/biotech/blueprint-tears-plans-dropping-2-lung-cancer-programs-after-seeing-early-clinical-data